Clinical trial
Multicentric Evaluation of Best Corrected Visual Acuity of the XEN Implant Versus Classic Trabeculectomy in Open Angle Glaucoma Subjects
NCT05439161 is registered in ClinicalTrials.gov with Prof. Dr. Herbert Reitsamer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric Evaluation of Best Corrected Visual Acuity of the XEN Implant Versus Classic Trabeculectomy in Open Angle Glaucoma Subjects
- Lead sponsor
- Prof. Dr. Herbert Reitsamer
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 20, 2023
- Completion date
- September 30, 2026
- Enrollment
- 196 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pigmentary dispersion glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma